TNF antagonists safe for IBD patients with COVID-19
25 Aug 2020
bởiTristan Manalac
The use of tumour necrosis factor (TNF) antagonists does not lead to a worse prognosis in patients with coronavirus disease 2019 (COVID-19), according to a new study. Systemic corticosteroids, on the other hand, appear to be a significant risk factor for severe disease.